Whitehawk Therapeutics (WHWK) Return on Invested Capital (2021 - 2023)

Whitehawk Therapeutics (WHWK) has 3 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2023.

• Return on Invested Capital for Q4 2023 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was 0.01% (changed N/A YoY), and the FY2021 annual result was 0.02%, down 2.0% from the prior year.
• Return on Invested Capital fell to 0.01% in Q4 2023 per WHWK's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.0% in Q3 2022 and troughed at 0.01% in Q3 2021.
• A 3-year average of 0.01% and a median of 0.01% in 2021 frame the typical range for Return on Invested Capital.
• The sharpest annual moves came in 2022 and 2023: Return on Invested Capital rose 1 bps in 2022, then changed 0 bps in 2023.
• A 3-year view of Return on Invested Capital shows it stood at 0.01% in 2021, then surged by 41 bps to 0.0% in 2022, then tumbled by 42 bps to 0.01% in 2023.
• Business Quant data shows WHWK's Return on Invested Capital at 0.01% in Q4 2023, 0.01% in Q3 2023, and 0.0% in Q3 2022.